Capital Com MENA Securities Trading LLC is regulated by the Capital Market Authority.
Open platformOpen platform

TMC Life Sciences Announces 24th Annual General Meeting

By Public Technologies
  • TMC Life Sciences will hold its annual general meeting on November 24, 2026, at M World Hotel in Petaling Jaya.
  • Shareholders will consider authorizing share issuance of up to 10% of issued shares, with a waiver of preemptive rights.
  • A proposed final single-tier dividend totals 0.5763 sen per ordinary share for the financial year ended June 30, 2026.
  • Subject to approval, the dividend is payable January 6, 2027, to shareholders on record December 9, 2026.
  • Other proposals include directors' fees of RM 810,000 and benefits of RM 560,000 for the financial year ending June 30, 2028.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TMC Life Sciences Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3717730) on October 22, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.